Edition:
United Kingdom

People: Pulmatrix Inc (PULM.OQ)

PULM.OQ on NASDAQ Stock Exchange Capital Market

0.87USD
5:14pm BST
Change (% chg)

$0.01 (+1.52%)
Prev Close
$0.86
Open
$0.84
Day's High
$0.88
Day's Low
$0.84
Volume
30,472
Avg. Vol
56,636
52-wk High
$4.60
52-wk Low
$0.72

Higgins, Michael 

Mr. Michael J. Higgins is a Independent Director of the Company. Mr. Higgins was previously a director of Pulmatrix Operating from March 2015 until the date of the Merger. Mr. Higgins is currently an Entrepreneur-in-Residence at Polaris Partners and is a board member at Genocea Biosciences, Voyager Therapeutics and Private Equity Access Fund, II. Mr. Higgins served as senior vice president, chief operating officer and chief financial officer of Ironwood Pharmaceuticals Inc. and led its finance, operations and strategy efforts from 2003 to 2014 and through its initial public offering and the launch of its first commercial product. Prior to 2003, Mr. Higgins spent seven (7) years and held a variety of senior business positions at Genzyme Corporation, including vice president of corporate finance and vice president of business development. Prior to joining Genzyme Corporation, Mr. Higgins led Procept, Inc. from founding through its initial public offering. Mr. Higgins earned a B.S. from Cornell University and an M.B.A. from the Amos Tuck School of Business Administration at Dartmouth College.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --